Year |
Citation |
Score |
2023 |
Maeyouf K, Sakpakdeejaroen I, Somani S, Meewan J, Ali-Jerman H, Laskar P, Mullin M, MacKenzie G, Tate RJ, Dufès C. Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells. Pharmaceutics. 15. PMID 38004621 DOI: 10.3390/pharmaceutics15112643 |
0.825 |
|
2023 |
Laskar P, Dhasmana A, Kotnala S, Jaggi M, Yallapu MM, Chauhan SC. Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy. Pharmaceutics. 15. PMID 37242568 DOI: 10.3390/pharmaceutics15051326 |
0.478 |
|
2022 |
Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. Journal of Advanced Research. PMID 36368516 DOI: 10.1016/j.jare.2022.11.001 |
0.452 |
|
2022 |
Meewan J, Somani S, Almowalad J, Laskar P, Mullin M, MacKenzie G, Khadke S, Perrie Y, Dufès C. Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells. International Journal of Nanomedicine. 17: 2809-2822. PMID 35791309 DOI: 10.2147/IJN.S366138 |
0.715 |
|
2022 |
Almowalad J, Laskar P, Somani S, Meewan J, Tate RJ, Dufès C. Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells. International Journal of Nanomedicine. 17: 1409-1421. PMID 35369035 DOI: 10.2147/IJN.S347574 |
0.756 |
|
2022 |
Meewan J, Somani S, Laskar P, Irving C, Mullin M, Woods S, Roberts CW, Alzahrani AR, Ferro VA, McGill S, Weidt S, Burchmore R, Dufès C. Limited Impact of the Protein Corona on the Cellular Uptake of PEGylated Zein Micelles by Melanoma Cancer Cells. Pharmaceutics. 14. PMID 35214171 DOI: 10.3390/pharmaceutics14020439 |
0.804 |
|
2021 |
Laskar P, Dufès C. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications. Nanoscale Advances. 3: 6007-6026. PMID 34765868 DOI: 10.1039/d1na00536g |
0.323 |
|
2021 |
Dhasmana A, Dhasmana S, Kotnala S, A A, Kashyap VK, Shaji PD, Laskar P, Khan S, Pellicano R, Fagoonee S, Haque S, Yallapu MM, Chauhan SC, Jaggi M. A topography of immunotherapies against gastrointestinal malignancies. Panminerva Medica. PMID 34664484 DOI: 10.23736/S0031-0808.21.04541-9 |
0.384 |
|
2021 |
Almowalad J, Somani S, Laskar P, Meewan J, Tate RJ, Mullin M, Dufès C. Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro. International Journal of Nanomedicine. 16: 4391-4407. PMID 34234433 DOI: 10.2147/IJN.S316830 |
0.766 |
|
2021 |
Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Dufès C. Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles. International Journal of Nanomedicine. 16: 2615-2631. PMID 33854311 DOI: 10.2147/IJN.S293480 |
0.805 |
|
2021 |
Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Nanotechnology Synergised Immunoengineering for Cancer. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 33774162 DOI: 10.1016/j.ejpb.2021.03.010 |
0.388 |
|
2021 |
Laskar P, Somani S, Mullin M, Tate RJ, Warzecha M, Bowering D, Keating P, Irving C, Leung HY, Dufès C. Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells. Biomaterials Science. PMID 33404026 DOI: 10.1039/d0bm01441a |
0.828 |
|
2020 |
Sakpakdeejaroen I, Somani S, Laskar P, Irving C, Mullin M, Dufès C. Anti-Tumor Activity of Intravenously Administered Plumbagin Entrapped in Targeted Nanoparticles. Journal of Biomedical Nanotechnology. 16: 85-100. PMID 31996288 DOI: 10.1166/jbn.2020.2874 |
0.815 |
|
2019 |
Laskar P, Somani S, Campbell SJ, Mullin M, Keating P, Tate RJ, Irving C, Leung HY, Dufès C. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. PMID 31612185 DOI: 10.1039/c9nr07254c |
0.827 |
|
2019 |
Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Dufès C. Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of Interdisciplinary Nanomedicine. 4: 54-71. PMID 31341642 DOI: 10.1002/jin2.56 |
0.82 |
|
2018 |
Laskar P, Somani S, Altwaijry N, Mullin M, Bowering D, Warzecha M, Keating P, Tate RJ, Leung HY, Dufès C. Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. Nanoscale. PMID 30488937 DOI: 10.1039/c8nr08141g |
0.825 |
|
2018 |
Somani S, Laskar P, Altwaijry N, Kewcharoenvong P, Irving C, Robb G, Pickard BS, Dufès C. PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. Scientific Reports. 8: 9410. PMID 29925967 DOI: 10.1038/s41598-018-27400-6 |
0.737 |
|
Show low-probability matches. |